Featured Article

Breathing New Life Into COPD and Asthma Therapy With Statins

Breathing New Life Into COPD and Asthma Therapy With Statins

Statins have anti-inflammatory and anti-oxidative effects, which could reduce exacerbations of both asthma and chronic obstructive pulmonary disease.

Latest Features

Breathing New Life Into COPD and Asthma Therapy With Statins

Breathing New Life Into COPD and Asthma Therapy With Statins

Statins have anti-inflammatory and anti-oxidative effects, which could reduce exacerbations of both asthma and chronic obstructive pulmonary disease.

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.

Statins Limit Vaccine Efficacy of Influenza Strain

Statins Limit Vaccine Efficacy of Influenza Strain

Statin use modified vaccine effectiveness and influenza risk for A(H3N2) infection but not for A(H1N1).

Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C

Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C

Vitamin D may influence cardiovascular disease risk via its effect on lipid levels.

Considering Cardiovascular Risks of Antidiabetic Drugs

Considering Cardiovascular Risks of Antidiabetic Drugs

A review of current antidiabetic drug treatments available and their individual cardiovascular risk profiles.

PCSK9 Inhibitors: Breakthrough in LDL-C Reduction, But Comes at a Cost

PCSK9 Inhibitors: Breakthrough in LDL-C Reduction, But Comes at a Cost

PCSK9 inhibitors may offer hope to patients with familial hypercholesterolemia who cannot tolerate or achieve goal LDL-C levels with statins.

LATEST NEWS

Breathing New Life Into COPD and Asthma Therapy With Statins

Breathing New Life Into COPD and Asthma Therapy With Statins

Statins have anti-inflammatory and anti-oxidative effects, which could reduce exacerbations of both asthma and chronic obstructive pulmonary disease.

Outcomes-Based Pricing Does Not Cut Costs of PCSK9 Inhibitors

Outcomes-Based Pricing Does Not Cut Costs of PCSK9 Inhibitors

Incremental cost-effectiveness ratio for PCSK9 inhibitor improved marginally in 3 refund scenarios.

Only Half of Adults With Familial Hypercholesterolemia on Statins

Only Half of Adults With Familial Hypercholesterolemia on Statins

Only 30.3 percent of patients with definite or probable FH on statins take a high-intensity statin.

Metformin Use Linked to Reduced Risk for Statin-Associated Muscle Pain

Metformin Use Linked to Reduced Risk for Statin-Associated Muscle Pain

Statin-associated muscle pain can hinder medication adherence which could potentially lead to an increased risk of cardiovascular events.

Statins Do Not Affect Influenza Risk Following Vaccination

Statins Do Not Affect Influenza Risk Following Vaccination

Statin medications taken around the time of influenza vaccination do not appear to affect the risk for influenza in older patients.

LDL-C Levels With Intensive Treatment for Autosomal Recessive Hypercholesterolemia

LDL-C Levels With Intensive Treatment for Autosomal Recessive Hypercholesterolemia

For patients with autosomal recessive hypercholesterolemia, low-density lipoprotein cholesterol levels remain high despite intensive treatment.

Accuracy of New Estimation Method for Low-Density Lipoprotein Cholesterol Levels

Accuracy of New Estimation Method for Low-Density Lipoprotein Cholesterol Levels

An adjustable triglyceride/very low-density lipoprotein cholesterol ratio based on triglycerides and non-high-density lipoprotein cholesterol is more accurate than the fixed Friedewald estimation.

CVD, Mortality May Be Affected by Visit-to-Visit Fasting Plasma Glucose Variability

CVD, Mortality May Be Affected by Visit-to-Visit Fasting Plasma Glucose Variability

Patients with visit-to-visit variability of fasting plasma glucose may have a higher risk of developing cardiovascular disease and all-cause mortality.

FDA Approves PCSK9 Inhibitor for Stroke, MI Prevention

FDA Approves PCSK9 Inhibitor for Stroke, MI Prevention

The FDA has approved evolocumab for the prevention of heart attacks.

Almonds With or Without Dark Chocolate May Improve Lipid Profiles in Controlled Feeding Conditions

Almonds With or Without Dark Chocolate May Improve Lipid Profiles in Controlled Feeding Conditions

Lipid profiles of overweight people can be improved by eating raw almonds, dark chocolate, and cocoa.

Sign Up for Free e-Newsletters